Day: July 26, 2024

VANCOUVER, British Columbia, July 25, 2024 (GLOBE NEWSWIRE) — Alaska Energy Metals Corporation (TSX-V: AEMC, OTCQB: AKEMF) (“AEMC” or the “Company”) announces that it has been requested by OTC Markets Group Inc. (“OTC Markets”) to issue this statement about promotional activity concerning its common shares (the “Shares”) traded on the OTCQB Venture Market (“OTCQB”) (operated by OTC Markets). On July 23, 2024, OTC Markets informed the Company that it became aware of certain promotional activities concerning the Company and its Shares traded on the OTCQB, including the distribution of three email newsletters (the “Promotional Newsletters”) published by Wealth Research Group LLC, an affiliate of Gold Standard Media, LLC (“Gold Standard”) discussing the Company, its business, the economy, and the battery metals and nickel market generally. On...

SHANGHAI and NEW YORK, July 25, 2024 (GLOBE NEWSWIRE) — On July 19, 2024, TH International Limited, (Nasdaq:THCH), the exclusive operator of Tim Hortons coffee shops in China (“Tims China” or the “Company”) , received a notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”), stating that the Company’s ordinary shares, par value $0.00000939586994067732 per share (the “ordinary shares”), fail to comply with the $1.00 minimum bid price requirement for continued listing on Nasdaq in accordance with Nasdaq Listing Rule 5550(a)(2) based upon the closing bid price of the ordinary shares for the 30 consecutive business days prior to the date of the Notice. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial period of 180 calendar days, or until January 15, 2025, to regain compliance with the...

$8 million grant funds development of NXC-201 in relapsed/refractory AL Amyloidosis LOS ANGELES, CA, July 25, 2024 (GLOBE NEWSWIRE) — Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us”, “IMMX”) (Nasdaq: IMMX), a clinical-stage biopharmaceutical company trailblazing cell therapies in AL Amyloidosis and autoimmune disease, today announced that the California Institute for Regenerative Medicine (CIRM) has awarded Immix Biopharma cell therapy division Nexcella an $8 million CLIN2 grant award to support clinical development of chimeric antigen receptor T-cell (CAR-T) therapy NXC-201 for the treatment of relapsed/refractory AL Amyloidosis. “AL amyloidosis is an unmet medical need, and current approved therapies for this rare disease are mostly not well tolerated and have not led to sustained remissions,” said Dr. Abla Creasey,...

General Motors Reveals Third Corvette Model To Feature Company’s Carbon Fiber WheelsGEELONG, Australia, July 25, 2024 (GLOBE NEWSWIRE) — Carbon Revolution plc (Nasdaq: CREV) (the “Company”), a Tier 1 OEM supplier and the leading global manufacturer of lightweight advanced technology automotive carbon fiber wheels, today announced that it will supply the carbon fiber wheels available on the just-revealed Chevrolet Corvette ZR1. “It has been a great honor to work with General Motors (GM) again. This will be the third Corvette to feature our carbon fiber wheels,” said Carbon Revolution CEO Jake Dingle. “Our team harnessed its extensive engineering and manufacturing experience to come up with a wheel befitting of the highest-performance Corvette we’ve ever seen.” Carbon Revolution’s one-piece carbon fiber wheels are significantly...

Montevideo, July 25, 2024 (GLOBE NEWSWIRE) — MONTEVIDEO, Uruguay; July 25, 2024; (GLOBE NEWSWIRE) — MercadoLibre, Inc. (Nasdaq: MELI) (http://www.mercadolibre.com) announces that it intends to release financial results for its second fiscal quarter ending June 30, 2024, on August 1, 2024. The Company will host its earnings results video conference, as well as a conference call and audio webcast, on August 1, at 5:00 p.m. Eastern Time. In order to access our video webcast and the live audio, investors, analysts and the market in general may access the following link https://edge.media-server.com/mmc/p/wxyza35x and register to attend the live event. To participate in our conference call Q&A, investors, analysts and the market in general may access the following link https://register.vevent.com/register/BI2845308aed8a4e48be500f4ec4a07bec to...

Toronto, July 25, 2024 (GLOBE NEWSWIRE) — Faircourt Asset Management Inc., as Manager of the Faircourt Fund (NEO:FGX), is pleased to announce the monthly distribution payable on the Shares of the below listed Fund.Faircourt Funds Trading Symbol Distribution Amount (per share/unit) Ex-Dividend Date Record Date Payable DateFaircourt Gold Income Corp. FGX $0.024 July 31, 2024 July 31, 2024 August 15, 2024Faircourt Asset Management Inc. is the Investment Advisor for Faircourt Gold Income Corp. This press release is not for distribution in the United States or over United States wire services. For further information on the Faircourt Funds, please visit www.faircourtassetmgt.com or please contact 1-800-831-0304. You will usually pay brokerage fees to your dealer if you purchase or sell Shares of the Fund on the NEO Exchange...